This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Oct;21(5):616-24.

doi: 10.1583/14-4692C.1.

Commentary: myths and proofs of angiosome applications in CLI: where do we stand?

Vlad-Adrian Alexandrescu¹

Affiliations

PMID: 25290787
DOI: 10.1583/14-4692C.1

Comment

Commentary: myths and proofs of angiosome applications in CLI: where do we stand?

Vlad-Adrian Alexandrescu. J Endovasc Ther. 2014 Oct.

. 2014 Oct;21(5):616-24.

doi: 10.1583/14-4692C.1.

Author

Vlad-Adrian Alexandrescu¹

Affiliation

¹ General, Thoracic, and Vascular Surgery Department, Princess Paola Hospital, Marche-en-Famenne, Belgium.

PMID: 25290787
DOI: 10.1583/14-4692C.1

No abstract available

PubMed Disclaimer

Comment on

Impact of angiosome-oriented revascularization on clinical outcomes in critical limb ischemia patients without concurrent wound infection and diabetes.
Iida O, Takahara M, Soga Y, Yamauchi Y, Hirano K, Tazaki J, Yamaoka T, Suematsu N, Suzuki K, Shintani Y, Miyashita Y, Uematsu M. Iida O, et al. J Endovasc Ther. 2014 Oct;21(5):607-15. doi: 10.1583/14-4692R.1. J Endovasc Ther. 2014. PMID: 25290786

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal